A new, highly sensitive method to detect genetic variations that initiate colon cancer could be readily used for noninvasive colon cancer screening, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Researchers from The University of Manchester and Central Manchester University Hospitals NHS Trust have identified proteins in the blood that could be used to predict whether a woman in her first pregnancy is at increased risk of developing pre-eclampsia.
EarlySense, the market leader in Proactive Patient Care Solutions™, announced today that the company has been granted three United States patents. The first, US Patent number , was granted for the ability of the EarlySense technology to monitor and predict congestive heart failure (CHF) and asthma attacks.
Despite all the research done on Alzheimer’s, there is still no early diagnostic tool for the disease. By looking at the brain wave components of individuals with the disease, Professor Tiago H. Falk of INRS’s Centre Énergie Matériaux Télécommunications has identified a promising avenue of research that may not only help diagnose the disease, but also assess its severity.
Texas mobile health startup Vital Art & Science is looking for a pharmaceutical industry partner now that it's raised $550,000 in support of its MyVisionTrack iPhone hyperacuity test. MyVisionTrack is an FDA-cleared smartphone app for detecting age-related macular degeneration and other age-related visual impairments.
Researchers from University Hospitals Case Medical Center have published findings that a new form of imaging -- PET/MRI -- is promising for several types of cancer. In an article titled "PET/MRI: Applications in Clinical Imaging," published in the September issue of Current Radiology Reports, the authors outline their initial clinical experience in diagnosing and staging cancer patients with this novel technology.
A recently reported blood test for the early detection of organ transplant injury could enable more timely therapeutic intervention in transplant patients and thus help to avoid longer term damage. As described by scientists at the University Medical Center Göttingen and Chronix Biomedical, a molecular diagnostics company...
In the United States there are millions of sports related concussions each year, but many go undiagnosed because for some athletes, the fear of being benched trumps the fear of permanent brain damage, and there is no objective test available to accurately diagnose concussions on the sidelines. Researchers at San Diego State University have set out to change that.
Innovative control technology offers medical professionals and technicians the potential to do much more with diagnostic imaging equipment. “A New Dimension in Diagnostics,” this issue's cover story, looks at intuitive controls for radiological applications.
Leading companies and institutes in protein diagnostics and micro-nano-bio research, including Philips, imec, Hytest, PolyAn, Bremen University, and Eindhoven University of Technology, have joined forces to investigate next-generation technologies with the goal of enabling new, highly sensitive, point-of-care blood tests.
Bodkin Design and Engineering, LLC is an electro-optic system and solutions research and design firm serving the bio-medical and healthcare industries. Bodkin developed a beta prototype by using unique biomedical sensors to monitor Capillary Refill Time more objectively.
A team led by University of Washington engineers has created a patch with tiny, biodegradable needles that can penetrate the skin and precisely deliver a tuberculosis test. The researchers published their results online Aug. 26 in the journal Advanced Healthcare Materials.
Volcano Corporation Announces Execution Of Agreement To Purchase Pioneer PlusT Re-Entry Catheter Product Line From MedtronicAugust 26, 2013 4:05 pm | by The Associated Press | News | Comments
Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today it has signed an agreement to acquire the Pioneer PlusT diagnostic ultrasound ...
Nanomedicine refers to highly specific medical intervention at the molecular level for curing disease or repairing damaged tissues. Though in its infancy, could we be looking at the future of medicine? Early clinical trials certainly look promising.
The ability to measure brain functions non-invasively is important both for clinical diagnoses and research in Neurology and Psychology. Two main imaging techniques are used: positron emission tomography (PET), which reveals metabolic processes in the brain; and activity of different brain regions is measured on the basis of the cells’ oxygen consumption by magnetic resonance imaging (MRI).
A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
BD, a leading global medical technology company, supports the U.S. Food and Drug Administration's (FDA's) proposed reclassification of rapid influenza detection tests. A hearing, held on June 13th by FDA's CDRH Microbiology Devices Advisory Committee Meeting, examined the FDA's proposal to reclassify rapid influenza detection tests (RIDTs) currently regulated as Class I devices, into Class II devices.
A new scanning technique developed by Danish and US researchers reveals how susceptible patients with aggressive brain cancer are to the drugs they receive. The research behind the ground-breaking technique has just been published in Nature Medicine.
A lightweight and field-portable device invented at UCLA that conducts kidney tests and transmits data through a smartphone attachment may significantly reduce the need for frequent office visits by people with diabetes and others with chronic kidney ailments.
Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery disease, today announced that it has received a $25 million equity investment from Nipro Corporation. This investment builds on Infraredx’s exclusive agreement with Nipro for distribution of its TVC Imaging System in Japan, the world’s largest intravascular imaging market.
For the two-thirds of lung cancer patients with locally advanced or metastatic disease, tumor size is not used currently to predict overall survival times. A new study, however, led by UT Southwestern Medical Center researchers has shown that even in advanced stages total tumor size can have a major impact on survival.
In a study reported Aug. 20 in the advance online edition of the Nature Publishing Group journal Molecular Psychiatry, the researchers said the biomarkers were found at significantly higher levels in the blood of both bipolar disorder patients with thoughts of suicide as well in a group of people who had committed suicide.
Eclipse Breast Health Technologies Inc., a health products design and development company, today announced Eclipse is executing a crowd sourcing campaign on Indiegogo to raise $650,000 to bring Eclipse to the market as soon as possible so it can benefit women in early detection of breast abnormalities...
Using inertial sensors, a research group has managed to measure horse movement as well as the timing of the hoof's contact with the ground very accurately. Using this new method, veterinarians will be able to analyse the movement patterns of horses with lameness much better than before.
A Rice University laboratory has improved upon its ability to determine molecular structures in three dimensions in ways that challenge long-used standards. By measuring the vibrations between atoms using femtosecond-long laser pulses, the Rice lab is able to discern the positions of atoms within molecules without the restrictions imposed by X-ray diffraction and nuclear magnetic resonance imaging.